BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36054458)

  • 1. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.
    Kim BS; Inan S; Ständer S; Sciascia T; Szepietowski JC; Yosipovitch G
    Exp Dermatol; 2022 Dec; 31(12):1900-1907. PubMed ID: 36054458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
    Soeberdt M; Kilic A; Abels C
    Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous difelikefalin for the treatment of hemodialysis pruritus.
    Mahmoud RH; Mahmoud O; Yosipovitch G
    Expert Rev Clin Immunol; 2024; 20(1):31-37. PubMed ID: 37847514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.
    Elmariah S; Chisolm S; Sciascia T; Kwatra SG
    JAAD Int; 2022 Jun; 7():156-163. PubMed ID: 35497636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Delta-Opioid Receptor Bidirectionally Modulates Itch.
    Smith KM; Nguyen E; Ross SE
    J Pain; 2023 Feb; 24(2):264-272. PubMed ID: 36464136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies.
    Reich A; Szepietowski JC
    Curr Pharm Des; 2012; 18(37):6021-4. PubMed ID: 22747545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
    Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
    Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development.
    Cevikbas F; Steinhoff M; Ikoma A
    CNS Neurosci Ther; 2011 Dec; 17(6):742-9. PubMed ID: 20950328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.
    Chakrabarti S; Liu NJ; Gintzler AR
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20115-9. PubMed ID: 21041644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.
    Jain MR; Patel RB; Prajapati KD; Vyas P; Bandyopadhyay D; Prajapati V; Bahekar R; Patel PN; Kawade HM; Kokare DM; Pawar V; Desai R
    Eur J Pharmacol; 2022 Jun; 924():174961. PubMed ID: 35443192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans.
    Inan S; Cowan A
    Handb Exp Pharmacol; 2022; 271():275-292. PubMed ID: 33296031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.
    Bigliardi-Qi M; Gaveriaux-Ruff C; Pfaltz K; Bady P; Baumann T; Rufli T; Kieffer BL; Bigliardi PL
    J Invest Dermatol; 2007 Jun; 127(6):1479-88. PubMed ID: 17185983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis.
    Inan S; Torres-Huerta A; Jensen LE; Dun NJ; Cowan A
    Eur J Pharmacol; 2019 Dec; 864():172702. PubMed ID: 31568781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible roles of epidermal opioid systems in pruritus of atopic dermatitis.
    Tominaga M; Ogawa H; Takamori K
    J Invest Dermatol; 2007 Sep; 127(9):2228-35. PubMed ID: 17611580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraxial opioid-induced itch and its pharmacological antagonism.
    Ko MC
    Handb Exp Pharmacol; 2015; 226():315-35. PubMed ID: 25861787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of butorphanol on morphine-induced itch and analgesia in primates.
    Lee H; Naughton NN; Woods JH; Ko MC
    Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical κ-opioid receptor agonist asimadoline improves dermatitis in a canine model of atopic dermatitis.
    Marsella R; Ahrens K; Wilkes R; Soeberdt M; Abels C
    Exp Dermatol; 2022 Apr; 31(4):628-632. PubMed ID: 34839557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Receptors in Psoriatic Skin: Relationship with Itch.
    Kupczyk P; Reich A; Hołysz M; Gajda M; Wysokińska E; Kobuszewska A; Nevozhay D; Nowakowska B; Strzadała L; Jagodziński PP; Szepietowski JC
    Acta Derm Venereol; 2017 May; 97(5):564-570. PubMed ID: 27958613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia.
    Sun J; Chen SR; Chen H; Pan HL
    J Physiol; 2019 Mar; 597(6):1661-1675. PubMed ID: 30578671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.